Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Description of a Clinical Score to Identify PMBL Patients at High Risk of Early-Failure after Rituximab Doxorubicin Back-Bone Chemoimmunotherapy. a FIL Real-World Study

Emilio Iannitto, Monica Balzarotti, Maurizio Martelli, Pier Luigi Zinzani, Alessandra Tucci, Alice Di Rocco, Federica Cavallo, Sara Usai, Anna Guidetti, Emanuele Ravano, Franceso Merli, Barbara Botto, Matteo Pelosini, Cristina Tecchio, Michele Spina, Enrico Derenzini, Silvia Finotto, Brunella Mola, Antonio Pinto, Manuela Zanni, Roberta Battistini, Stefan Hohaus, Irene Dogliotti, Guido Gini, Vittorio Ruggero Zilioli, Sonya De Lorenzo, Anna Dodero, Alessandro Broccoli, Alessandro Maggi, Clara Mannarella, Annalisa Chiarenza, Domenico Pastore, Pellegrino Musto, Caterina Stelitano, Francesco Di Raimondo, Nicola Cascavilla, Nicola Di Renzo, Marilena Salerno, Renato Scalone, Luca Nassi, Attilio Guarini, Caterina Patti, Vita Polizzi, Gabriella Amato, Giovannino Ciccone, Andrea Evangelista, Agostino La Porta, Angelo Genua, Donato Mannina, Ciro Maria Improta, Alessandro Re, Fabrizio Lo Presti, Rosalba Donatella Calogero, Maurizio Musso, Ugo Consoli

Blood (2023) 142 (Supplement 1): 986.

https://doi.org/10.1182/blood-2023-178197

Published: 2023

Journal Articles

The Impact of Different Mobilization Strategies in the Setting of Multiple Myeloma

Francesco Mazziotta, MD, Gabriele Buda, MD PhD, Nadia Cecconi, MD, Giulia Cervetti, MD, Lorenzo Iovino, MD, Enrico Orciuolo, MD PhD, Matteo Pelosini, MD PhD, Edoardo Benedetti, MD, Francesco Caracciolo, MD, Giovanni Carulli, MD, Sara Galimberti, MD PhD, Mario Petrini, MD PhD

Blood (2019) 134 (Supplement_1): 3254.

https://doi.org/10.1182/blood-2019-126118

Published: 2019

Journal Articles

Mantle Cell Lymphoma Mimicking Mucosa-Associated Lymphoid Tissue (MALT) Lymphomas: A Pathological Characterization (on behalf of the "Fondazione Italiana Linfomi (FIL) - Postgraduate Master Course")

Blood (2017) 130 (Supplement 1): 4049.

https://doi.org/10.1182/blood.V130.Suppl_1.4049.4049

Published: 2017

Journal Articles

Safety and Efficacy of Pegylated Liposomal Doxorubicin In Combination with Dexamethasone and Bortezomib (VMD) or Lenalidomide (RMD) In Multiple Myeloma Refractory/Relapsed Patients

Gabriele Buda, M.D., PhD, Enrico Orciuolo, Sara Galimberti, Matteo Pelosini, Mario Petrini, MD

Blood (2010) 116 (21): 5033.

https://doi.org/10.1182/blood.V116.21.5033.5033

Published: 2010

Journal Articles

Optimizing Follow up Schedule for Non Hodgkin Lymphoma' Patients by Multi-Objective Analysis.

Matteo Pelosini, M.D., Flavio Baronti, Francesco Caracciolo, Sara Galimberti, Edoardo Benedetti, Federico Papineschi, Enrico Orciuolo, Gabriele Buda, Antonina Starita, Mario Petrini, MD

Blood (2009) 114 (22): 3945.

https://doi.org/10.1182/blood.V114.22.3945.3945

Published: 2009

Journal Articles

Early Diagnosis of Neutropenic Enterocolitis by Ultrasound Sonography.

Edoardo Benedetti, Federico Simonetti, MD, Francesco Caracciolo, Federico Papineschi, Benedetto Bruno, MD, PhD, Matteo Pelosini, Daniele Focosi, M.D., Sara Galimberti, Mario Petrini, MD

Blood (2009) 114 (22): 4742.

https://doi.org/10.1182/blood.V114.22.4742.4742

Published: 2009

Journal Articles

Contrast Enhanced Ultrasound Sonography in Intestinal Acute Graft Versus Host Disease: Advantages of Non-Invasive Anatomic and Physiologic Measurements.

Edoardo Benedetti, Benedetto Bruno, MD, PhD, George B. McDonald, MD, Francesco Caracciolo, Federico Papineschi, Matteo Pelosini, Daniele Focosi, M.D., Sara Galimberti, Mario Petrini, MD

Blood (2009) 114 (22): 4493.

https://doi.org/10.1182/blood.V114.22.4493.4493

Published: 2009

Journal Articles

Aggressive Non Hodgkin lymphoma'patients Treated by High Dose Chemotherapy and Immunotherapy Has a Lower Relapse Rate: Results of a Computer Science Analysis.

Matteo Pelosini, M.D., Flavio Baronti, Francesco Caracciolo, Sara Galimberti, Edoardo Benedetti, Federico Papineschi, Enrico Orciuolo, Gabriele Buda, Antonina Starita, Mario Petrini, MD

Blood (2009) 114 (22): 4772.

https://doi.org/10.1182/blood.V114.22.4772.4772

Published: 2009

Journal Articles

The Role of Imaging in Relapse Detection During Follow up: a Fifteen-Year Single Center Experience.

Matteo Pelosini, M.D., Francesco Caracciolo, Sara Galimberti, Edoardo Benedetti, Federico Papineschi, Enrico Orciuolo, Gabriele Buda, Mario Petrini, MD

Blood (2009) 114 (22): 5007.

https://doi.org/10.1182/blood.V114.22.5007.5007

Published: 2009

Journal Articles

Reduced-Intensity Regimens for Allogeneic Stem Cell Transplantation Improve the Outcome in Advanced Multiple Myeloma

Suzanne M. Cole, MD, Rima Saliba, Matteo Pelosini, M.D., Floralyn L Mendoza, Donna Weber, MD, Michael Wang, MD, Sheeba Thomas, MD, Robert Z. Orlowski, MD, PhD, Jatin Shah, MD, Amin Alousi, MD, Chitra Hosing, MD, Uday Popat, MD, Partow Kebriaei, MD, Paolo Anderlini, MD, Issa F. Khouri, Richard Champlin, MD, Sergio Giralt, MD, Muzaffar H. Qazilbash, MD

Blood (2008) 112 (11): 3298.

https://doi.org/10.1182/blood.V112.11.3298.3298

Published: 2008

Journal Articles

Myeloablative, Reduced Toxicity IV Busulfan/Fludarabine (BuFlu) and Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for Patients in the 6th and 7th Decades of Life with AML or MDS

Gheath Alatrash, Borje S. Andersson, Matteo Pelosini, Gabrila Rondon, Muzaffar H. Qazilbash, Sergio Giralt, Leandro de Padua Silva, Chitra Hosing, Partow Kebriaei, Weiqing Zhang, Rima Saliba, Richard E. Champlin, Marcos De Lima

Blood (2008) 112 (11): 2999.

https://doi.org/10.1182/blood.V112.11.2999.2999

Published: 2008

Journal Articles

Platelet Recovery Prior to Stem Cell Transplantation Predicts for Post- Transplant Outcomes in Patients with AML

Gheath Alatrash, Matteo Pelosini, Rima M Saliba, Gabriela Rondon, Weiqing Zhang, Sergio Giralt, Partow Kebriaei, Amin Alousi, Issa F Khouri, Richard E Champlin, Marcos De Lima

Blood (2008) 112 (11): 3000.

https://doi.org/10.1182/blood.V112.11.3000.3000

Published: 2008

Journal Articles

A Randomized Phase II Trial of High-Dose Melphalan, Ascorbic Acid and Arsenic Trioxide with or without Bortezomib in Multiple Myeloma

Muzaffar H. Qazilbash, Rima M. Saliba, Matteo Pelosini, M.D., Chitra M Hosing, Floralyn L Mendoza, Eric Han, Michael Wang, MD, Donna M. Weber, Amin M. Alousi, Paolo Anderlini, Partow Kebriaei, Issa F. Khouri, Uday R Popat, Marcos De Lima, Robert Z. Orlowski, MD, PhD, Richard E. Champlin, Sergio A. Giralt

Blood (2008) 112 (11): 3320.

https://doi.org/10.1182/blood.V112.11.3320.3320

Published: 2008

Journal Articles

In Vivo Purging with Hyper-CVAD Plus Rituximab Followed by Autologous Stem Cells Transplant and Rituximab Maintenance in Newly Diagnosed Mantle Cell Lymphoma: A Pilot Study for GISL (Italian Cooperative Study Group for Lymphoma).

Edoardo Benedetti, MD, Francesco Caracciolo, MD, Sara Galimberti, MD, Federico Papineschi, MD, Matteo Pelosini, MD, Giulia Cervetti, MD, Maido Gioacchino Castiglioni, MD, Sandra Mechelli, MD, Paola Scatena, MD, Maura Brugiatelli, MD, Mario Petrini, MD

Blood (2005) 106 (11): 5494.

https://doi.org/10.1182/blood.V106.11.5494.5494

Published: 2005

NARROW

Description of a Clinical Score to Identify PMBL Patients at High Risk of Early-Failure after Rituximab Doxorubicin Back-Bone Chemoimmunotherapy. a FIL Real-World Study

The Impact of Different Mobilization Strategies in the Setting of Multiple Myeloma

Mantle Cell Lymphoma Mimicking Mucosa-Associated Lymphoid Tissue (MALT) Lymphomas: A Pathological Characterization (on behalf of the "Fondazione Italiana Linfomi (FIL) - Postgraduate Master Course")

Safety and Efficacy of Pegylated Liposomal Doxorubicin In Combination with Dexamethasone and Bortezomib (VMD) or Lenalidomide (RMD) In Multiple Myeloma Refractory/Relapsed Patients

Optimizing Follow up Schedule for Non Hodgkin Lymphoma' Patients by Multi-Objective Analysis.

Early Diagnosis of Neutropenic Enterocolitis by Ultrasound Sonography.

Contrast Enhanced Ultrasound Sonography in Intestinal Acute Graft Versus Host Disease: Advantages of Non-Invasive Anatomic and Physiologic Measurements.

Aggressive Non Hodgkin lymphoma'patients Treated by High Dose Chemotherapy and Immunotherapy Has a Lower Relapse Rate: Results of a Computer Science Analysis.

The Role of Imaging in Relapse Detection During Follow up: a Fifteen-Year Single Center Experience.

Reduced-Intensity Regimens for Allogeneic Stem Cell Transplantation Improve the Outcome in Advanced Multiple Myeloma

Myeloablative, Reduced Toxicity IV Busulfan/Fludarabine (BuFlu) and Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for Patients in the 6th and 7th Decades of Life with AML or MDS

Platelet Recovery Prior to Stem Cell Transplantation Predicts for Post- Transplant Outcomes in Patients with AML

A Randomized Phase II Trial of High-Dose Melphalan, Ascorbic Acid and Arsenic Trioxide with or without Bortezomib in Multiple Myeloma

In Vivo Purging with Hyper-CVAD Plus Rituximab Followed by Autologous Stem Cells Transplant and Rituximab Maintenance in Newly Diagnosed Mantle Cell Lymphoma: A Pilot Study for GISL (Italian Cooperative Study Group for Lymphoma).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only